Clinical Trial Update: Evaluation of Cyberknife Precision Radiation Delivery System for Unresectable Malignant Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

This update reports the completion of Phase 1 and Phase 2 trials evaluating the Cyberknife precision radiation delivery system for unresectable malignant lung c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Stanford University | Conditions: Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED